Person · CIK 1226488

John T Henderson

Director at Cytokinetics

Earlier: Myriad Genetics, Myrexis and Inveresk Research Group

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$11.6M

Noticed on Form 144$3.9M

Bought on Form 4$371K

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Cytokinetics CYTK	Common Stock	Directly	78,712	Oct 16, 2026 · Filing · EDGAR
Cytokinetics CYTK	Common Stock	by Spouse	83	Oct 16, 2026 · Filing · EDGAR
Cytokinetics CYTK	Non-Qualified Stock Option (Right to Buy) exercise $77.15, expires May 26, 2036, into Common Stock	Directly	4,301	May 27, 2026 · Filing · EDGAR
Myriad Genetics	Common Stock	Directly	76,040	Dec 5, 2019 · Filing · EDGAR
Myriad Genetics	Common Stock	by Spouse	2,050	Dec 5, 2019 · Filing · EDGAR
Myrexis	Common Stock	Directly	33,500	Jan 18, 2013 · Filing · EDGAR
Myrexis	Common Stock	By Spouse	75	Jan 18, 2013 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q2 2026	$1.5M	$1.3M	—
Q4 2025	$559K	$578K	—
Q2 2025	$123K	$127K	—
Q4 2024	$90K	$90K	—
Q2 2024	$682K	$682K	—
Q1 2024	$808K	$808K	—
Q4 2023	$89K	$89K	—
Q2 2023	$157K	$157K	—
Q3 2022	$1.2M	Not machine-readable	—
Q4 2021	$340K	Not machine-readable	—
Q2 2021	$78K	Not machine-readable	—
Q4 2020	$104K	Not machine-readable	—
Q4 2019	—	—	$216K
Q3 2018	$1.3M	Not machine-readable	—
Q3 2017	$909K	Not machine-readable	—
Q1 2017	—	—	$112K
Q3 2016	$615K	Not machine-readable	—
Q2 2014	$179K	Not machine-readable	—
Q1 2014	$945K	Not machine-readable	—
Q4 2012	$1.1M	Not machine-readable	—
Q2 2009	—	—	$10K
Q1 2009	$825K	Not machine-readable	—
Q2 2004	—	—	$34K

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 2, 2025 · 2 notices
May 5, 2026	20,000 · ~$1.3M	May 5, 2026	Sold as noticed Sold 20,000 at $75.97 on May 5 · $1.5M Form 4	Filing · EDGAR
Dec 2, 2025	8,750 · ~$578K	Dec 2, 2025	Sold as noticed Sold 8,750 at $63.90 on Dec 2 · $559K Form 4	Filing · EDGAR
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 11, 2024 · 2 notices
Apr 15, 2025	3,190 · ~$127K	Apr 15, 2025	Sold as noticed Sold 3,190 at $38.66 on Apr 15 · $123K Form 4	Filing · EDGAR
Dec 11, 2024	1,780 · ~$90K	Dec 11, 2024	Sold as noticed Sold 1,780 at $50.42 on Dec 11 · $90K Form 4	Filing · EDGAR
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 18, 2023 · 4 notices
Apr 25, 2024	10,562 · ~$682K	Apr 25, 2024	Sold as noticed Sold 10,562 at $64.54 on Apr 25 · $682K Form 4	Filing · EDGAR
Feb 14, 2024	5,000 · ~$382K	Feb 14, 2024	Sold as noticed Sold 5,000 at $76.48 on Feb 14 · $382K Form 4	Filing · EDGAR
Jan 12, 2024	5,000 · ~$426K	Jan 12, 2024	Sold as noticed Sold 5,000 at $85.14 on Jan 12 · $426K Form 4	Filing · EDGAR
Dec 18, 2023	2,458 · ~$89K	Dec 18, 2023	Sold as noticed Sold 2,458 at $36.34 on Dec 18 · $89K Form 4	Filing · EDGAR
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 22, 2022 · 1 notice
May 15, 2023	4,166 · ~$157K	May 15, 2023	Sold as noticed Sold 4,166 at $37.77 on May 15 · $157K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 25 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 7,259 at $54.94 on Sep 12, 2022 · $399K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 7,250 at $54.95 on Sep 12, 2022 · $398K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 7,250 at $54.94 on Sep 12, 2022 · $398K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 8,503 at $40.00 on Nov 5, 2021 · $340K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 1,100 at $23.31 on Apr 1, 2021 · $26K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 1,100 at $23.31 on Apr 1, 2021 · $26K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 1,133 at $24.00 on Apr 1, 2021 · $27K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 858 at $20.31 on Dec 31, 2020 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 1,500 at $28.00 on Oct 5, 2020 · $42K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 1,500 at $30.00 on Oct 5, 2020 · $45K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $40.17 on Jul 11, 2018 · $402K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $42.01 on Jul 11, 2018 · $420K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $44.00 on Jul 11, 2018 · $440K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $30.30 on Sep 1, 2017 · $303K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $30.30 on Sep 1, 2017 · $303K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $30.31 on Sep 1, 2017 · $303K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 2,007 at $20.21 on Sep 12, 2016 · $41K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 27,993 at $20.51 on Sep 9, 2016 · $574K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 5,000 at $35.70 on Jun 5, 2014 · $179K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 20,000 at $37.86 on Mar 7, 2014 · $757K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 5,000 at $37.59 on Mar 5, 2014 · $188K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 18,746 at $27.72 on Dec 10, 2012 · $520K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 11,254 at $27.60 on Dec 10, 2012 · $311K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $27.60 on Dec 10, 2012 · $276K	Filing · EDGAR
—	—	—	Notice not machine-readable Myriad Genetics: Sold 10,000 at $82.46 on Feb 5, 2009 · $825K	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Cytokinetics CYTK Director · filings 2009 to 2026 · sold $5.7M · bought $51K · $3.9M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 16, 2026	Grant or award from the company	+352	$63.92	$22K	78,712 direct	Filing · EDGAR
Jul 15, 2026	Grant or award from the company	+272	$82.62	$22K	78,360 direct	Filing · EDGAR
May 27, 2026	Grant or award from the company	+2,851			78,088 direct	Filing · EDGAR
May 27, 2026	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+4,301			4,301 direct	Filing · EDGAR
May 5, 2026	Option or RSU exercised or converted	+20,000	$7.61	$152K	95,237 direct	Filing · EDGAR
May 5, 2026	Sale under a 10b5-1 plan	−20,000	$75.97	$1.5M	75,237 direct	Filing · EDGAR
May 5, 2026	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−20,000			0 direct	Filing · EDGAR
Apr 15, 2026	Grant or award from the company	+325	$65.37	$21K	75,237 direct	Filing · EDGAR
Jan 15, 2026	Grant or award from the company	+334	$63.44	$21K	74,912 direct	Filing · EDGAR
Dec 2, 2025	Option or RSU exercised or converted	+8,750	$10.00	$88K	83,328 direct	Filing · EDGAR
Dec 2, 2025	Sale under a 10b5-1 plan	−8,750	$63.90	$559K	74,578 direct	Filing · EDGAR
Dec 2, 2025	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−8,750			0 direct	Filing · EDGAR
Oct 15, 2025	Grant or award from the company	+338	$62.80	$21K	74,578 direct	Filing · EDGAR
Jul 15, 2025	Grant or award from the company	+559	$38.01	$21K	74,240 direct	Filing · EDGAR
May 14, 2025	Grant or award from the company	+7,333			73,681 direct	Filing · EDGAR
May 14, 2025	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+10,880			10,880 direct	Filing · EDGAR
Apr 15, 2025	Grant or award from the company	+551	$38.56	$21K	66,348 direct	Filing · EDGAR
Apr 15, 2025	Option or RSU exercised or converted	+20,000	$6.21	$124K	69,538 direct	Filing · EDGAR
Apr 15, 2025	Sale under a 10b5-1 plan	−3,190	$38.66	$123K	66,348 direct	Filing · EDGAR
Apr 15, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−20,000			0 direct	Filing · EDGAR
Jan 2, 2025	Grant or award from the company	+434	$48.93	$21K	48,987 direct	Filing · EDGAR
Dec 11, 2024	Option or RSU exercised or converted	+1,780	$7.37	$13K	40,241 direct	Filing · EDGAR
Dec 11, 2024	Sale under a 10b5-1 plan	−1,780	$50.42	$90K	38,461 direct	Filing · EDGAR
Dec 11, 2024	Option or RSU exercised or converted	+10,092	$7.37	$74K	48,553 direct	Filing · EDGAR
Dec 11, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−1,780			10,092 direct	Filing · EDGAR
Dec 11, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−10,092			0 direct	Filing · EDGAR
Oct 1, 2024	Grant or award from the company	+403	$52.60	$21K	38,461 direct	Filing · EDGAR
Jul 1, 2024	Grant or award from the company	+388			38,058 direct	Filing · EDGAR
May 15, 2024	Grant or award from the company	+5,600			37,670 direct	Filing · EDGAR
May 15, 2024	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+3,636			3,636 direct	Filing · EDGAR
Apr 25, 2024	Sale under a 10b5-1 plan	−10,562	$64.54	$682K	32,070 direct	Filing · EDGAR
Feb 14, 2024	Option or RSU exercised or converted	+5,000	$4.44	$22K	47,632 direct	Filing · EDGAR
Feb 14, 2024	Sale under a 10b5-1 plan	−5,000	$76.48	$382K	42,632 direct	Filing · EDGAR
Feb 14, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			0 direct	Filing · EDGAR
Jan 12, 2024	Option or RSU exercised or converted	+5,000	$4.44	$22K	47,632 direct	Filing · EDGAR
Jan 12, 2024	Sale under a 10b5-1 plan	−5,000	$85.14	$426K	42,632 direct	Filing · EDGAR
Jan 12, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			5,000 direct	Filing · EDGAR
Jan 2, 2024	Grant or award from the company	+252	$84.12	$21K	42,632 direct	Filing · EDGAR
Dec 18, 2023	Option or RSU exercised or converted	+13,020	$6.72	$87K	44,838 direct	Filing · EDGAR
Dec 18, 2023	Sale under a 10b5-1 plan	−2,458	$36.34	$89K	42,380 direct	Filing · EDGAR
Dec 18, 2023	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−13,020			0 direct	Filing · EDGAR
Oct 2, 2023	Grant or award from the company	+762	$27.88	$21K	31,818 direct	Filing · EDGAR
Jul 3, 2023	Grant or award from the company	+636	$33.36	$21K	31,056 direct	Filing · EDGAR
May 15, 2023	Option or RSU exercised or converted	+4,166	$6.78	$28K	29,586 direct	Filing · EDGAR
May 15, 2023	Sale under a 10b5-1 plan	−4,166	$37.77	$157K	25,420 direct	Filing · EDGAR
May 15, 2023	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−4,166			0 direct	Filing · EDGAR
May 10, 2023	Grant or award from the company	+5,000			30,420 direct	Filing · EDGAR
May 10, 2023	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Apr 3, 2023	Grant or award from the company	+530	$37.71	$20K	25,420 direct	Filing · EDGAR
Jan 3, 2023	Grant or award from the company	+450	$44.35	$20K	24,890 direct	Filing · EDGAR
Oct 3, 2022	Grant or award from the company	+391	$51.11	$20K	24,440 direct	Filing · EDGAR
Sep 12, 2022	Option or RSU exercised or converted	+7,250	$4.02	$29K	31,299 direct	Filing · EDGAR
Sep 12, 2022	Sale under a 10b5-1 plan	−7,250	$54.94	$398K	24,049 direct	Filing · EDGAR
Sep 12, 2022	Option or RSU exercised or converted	+7,250	$4.02	$29K	31,299 direct	Filing · EDGAR
Sep 12, 2022	Sale under a 10b5-1 plan	−7,250	$54.95	$398K	24,049 direct	Filing · EDGAR
Sep 12, 2022	Option or RSU exercised or converted	+7,259	$4.02	$29K	31,308 direct	Filing · EDGAR
Sep 12, 2022	Sale under a 10b5-1 plan	−7,259	$54.94	$399K	24,049 direct	Filing · EDGAR
Sep 12, 2022	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−7,250			14,509 direct	Filing · EDGAR
Sep 12, 2022	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−7,250			7,259 direct	Filing · EDGAR
Sep 12, 2022	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−7,259			0 direct	Filing · EDGAR

66 earlier transactions are in the filing list below.

Myriad Genetics Director · filings 2004 to 2019 · sold $5.8M · bought $320K

Date	Transaction	Shares	Price	Value	Held after	Source
Dec 5, 2019	Grant or award from the company	+11,687			76,040 direct	Filing · EDGAR
Nov 7, 2019	Open-market or private purchase	+5,250	$23.46	$123K	64,353 direct	Filing · EDGAR
Nov 7, 2019	Open-market or private purchase	+1,750	$23.46	$41K	2,050 by Spouse	Filing · EDGAR
Nov 29, 2018	Grant or award from the company	+9,360			59,103 direct	Filing · EDGAR
Jul 11, 2018	Option or RSU exercised or converted	+10,000	$24.39	$244K	59,743 direct	Filing · EDGAR
Jul 11, 2018	Open-market or private sale	−10,000	$44.00	$440K	49,743 direct	Filing · EDGAR
Jul 11, 2018	Option or RSU exercised or converted	+10,000	$24.39	$244K	59,743 direct	Filing · EDGAR
Jul 11, 2018	Open-market or private sale	−10,000	$42.01	$420K	49,743 direct	Filing · EDGAR
Jul 11, 2018	Option or RSU exercised or converted	+10,000	$24.39	$244K	59,743 direct	Filing · EDGAR
Jul 11, 2018	Open-market or private sale	−10,000	$40.17	$402K	49,743 direct	Filing · EDGAR
Jul 11, 2018	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			20,000 direct	Filing · EDGAR
Jul 11, 2018	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			10,000 direct	Filing · EDGAR
Jul 11, 2018	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Nov 30, 2017	Grant or award from the company	+7,219			49,743 direct	Filing · EDGAR
Sep 1, 2017	Option or RSU exercised or converted	+10,000	$16.46	$165K	52,524 direct	Filing · EDGAR
Sep 1, 2017	Sale under a 10b5-1 plan	−10,000	$30.31	$303K	42,524 direct	Filing · EDGAR
Sep 1, 2017	Option or RSU exercised or converted	+10,000	$16.46	$165K	52,524 direct	Filing · EDGAR
Sep 1, 2017	Sale under a 10b5-1 plan	−10,000	$30.30	$303K	42,524 direct	Filing · EDGAR
Sep 1, 2017	Option or RSU exercised or converted	+10,000	$16.46	$165K	52,524 direct	Filing · EDGAR
Sep 1, 2017	Sale under a 10b5-1 plan	−10,000	$30.30	$303K	42,524 direct	Filing · EDGAR
Sep 1, 2017	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			20,000 direct	Filing · EDGAR
Sep 1, 2017	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			10,000 direct	Filing · EDGAR
Sep 1, 2017	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Feb 23, 2017	Open-market or private purchase	+3,600	$18.58	$67K	42,124 direct	Filing · EDGAR
Feb 23, 2017	Open-market or private purchase	+400	$18.57	$7K	42,524 direct	Filing · EDGAR
Feb 22, 2017	Open-market or private purchase	+2,000	$18.81	$38K	38,524 direct	Filing · EDGAR
Dec 1, 2016	Grant or award from the company	+15,024			36,524 direct	Filing · EDGAR
Sep 12, 2016	Option or RSU exercised or converted	+2,007	$10.60	$21K	23,507 direct	Filing · EDGAR
Sep 12, 2016	Open-market or private sale	−2,007	$20.21	$41K	21,500 direct	Filing · EDGAR
Sep 12, 2016	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−2,007			0 direct	Filing · EDGAR
Sep 9, 2016	Option or RSU exercised or converted	+27,993	$10.60	$297K	49,493 direct	Filing · EDGAR
Sep 9, 2016	Open-market or private sale	−27,993	$20.51	$574K	21,500 direct	Filing · EDGAR
Sep 9, 2016	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−27,993			2,007 direct	Filing · EDGAR
Dec 3, 2015	Grant or award from the company	+7,500			21,500 direct	Filing · EDGAR
Dec 4, 2014	Grant or award from the company	+10,000			14,000 direct	Filing · EDGAR
Jun 5, 2014	Option or RSU exercised or converted	+5,000	$7.60	$38K	9,000 direct	Filing · EDGAR
Jun 5, 2014	Open-market or private sale	−5,000	$35.70	$179K	4,000 direct	Filing · EDGAR
Jun 5, 2014	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−5,000			0 direct	Filing · EDGAR
Mar 7, 2014	Option or RSU exercised or converted	+20,000	$7.60	$152K	24,000 direct	Filing · EDGAR
Mar 7, 2014	Open-market or private sale	−20,000	$37.86	$757K	4,000 direct	Filing · EDGAR
Mar 7, 2014	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−20,000			5,000 direct	Filing · EDGAR
Mar 5, 2014	Option or RSU exercised or converted	+5,000	$7.60	$38K	9,000 direct	Filing · EDGAR
Mar 5, 2014	Open-market or private sale	−5,000	$37.59	$188K	4,000 direct	Filing · EDGAR
Mar 5, 2014	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−5,000			25,000 direct	Filing · EDGAR
Dec 5, 2013	Grant or award from the company Non-Qualified Stock Option (right to buy)	+30,000			30,000 direct	Filing · EDGAR
Dec 10, 2012	Option or RSU exercised or converted	+10,000	$6.09	$61K	14,000 direct	Filing · EDGAR
Dec 10, 2012	Open-market or private sale	−10,000	$27.60	$276K	4,000 direct	Filing · EDGAR
Dec 10, 2012	Option or RSU exercised or converted	+11,254	$6.90	$78K	15,254 direct	Filing · EDGAR
Dec 10, 2012	Open-market or private sale	−11,254	$27.60	$311K	4,000 direct	Filing · EDGAR
Dec 10, 2012	Option or RSU exercised or converted	+18,746	$6.90	$129K	22,746 direct	Filing · EDGAR
Dec 10, 2012	Open-market or private sale	−18,746	$27.72	$520K	4,000 direct	Filing · EDGAR
Dec 10, 2012	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−10,000			0 direct	Filing · EDGAR
Dec 10, 2012	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−11,254			18,746 direct	Filing · EDGAR
Dec 10, 2012	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−18,746			0 direct	Filing · EDGAR
Dec 5, 2012	Grant or award from the company Non-Qualified Stock Option (right to buy)	+30,000			30,000 direct	Filing · EDGAR
Dec 2, 2011	Grant or award from the company Non-Qualified Stock Option (right to buy)	+30,000			30,000 direct	Filing · EDGAR
Dec 3, 2010	Grant or award from the company Non-Qualified Stock Option (right to buy)	+30,000			30,000 direct	Filing · EDGAR
Nov 5, 2009	Grant or award from the company Non-Qualified Stock Option (right to buy)	+30,000			30,000 direct	Filing · EDGAR
May 13, 2009	Open-market or private purchase	+300	$32.73	$10K	300 by Spouse	Filing · EDGAR
Feb 5, 2009	Option or RSU exercised or converted	+10,000	$17.23	$172K	12,000 direct	Filing · EDGAR

9 earlier transactions are in the filing list below.

Myrexis Director · filings 2009 to 2013

Date	Transaction	Shares	Price	Value	Held after	Source
Jan 18, 2013	Option or RSU exercised or converted	+7,500	$1.07	$8K	8,500 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted	+7,500	$1.18	$9K	16,000 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted	+7,500	$1.65	$12K	23,500 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted	+7,500	$2.55	$19K	31,000 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted	+2,500	$0.95	$2K	33,500 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted Director Stock Option (Right to Buy)	−7,500			0 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted Director Stock Option (Right to Buy)	−7,500			0 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted Director Stock Option (Right to Buy)	−7,500			0 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted Director Stock Option (Right to Buy)	−7,500			0 direct	Filing · EDGAR
Jan 18, 2013	Option or RSU exercised or converted Director Stock Option (Right to Buy)	−2,500			0 direct	Filing · EDGAR
Dec 8, 2011	Grant or award from the company Director Stock Option (Right to Buy)	+16,250			16,250 direct	Filing · EDGAR
Nov 11, 2010	Grant or award from the company Director Stock Option (Right to Buy)	+16,250			16,250 direct	Filing · EDGAR
Jul 1, 2009	Grant or award from the company Director Stock Option (Right to Buy)	+25,000			25,000 direct	Filing · EDGAR

Inveresk Research Group Director · filings 2004 to 2004

Date	Transaction	Shares	Held after	Source
Oct 20, 2004	Returned to the company	−1,000	0 direct	Filing · EDGAR
Oct 20, 2004	Returned to the company Option to purchase Common Stock	−5,000	0 direct	Filing · EDGAR
Oct 20, 2004	Returned to the company Option to purchase Common Stock	−5,000	0 direct	Filing · EDGAR
Oct 20, 2004	Returned to the company Option to purchase Common Stock	−7,500	0 direct	Filing · EDGAR
May 4, 2004	Grant or award from the company Option to purchase Common Stock	+5,000	5,000 direct	Filing · EDGAR
Jun 28, 2003	Grant or award from the company Option to purchase Common Stock	+5,000	5,000 direct	Filing · EDGAR
Jun 28, 2003	Grant or award from the company Option to Purchase Common Stock	+5,000	5,000 direct	Filing · EDGAR

All 125 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Oct 20, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 16, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 27, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 5, 2026	Form 144	Cytokinetics CYTK	Filing · EDGAR
May 5, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 15, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 16, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 2, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Dec 2, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 16, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 16, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 14, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 16, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 16, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 15, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jan 6, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 12, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 11, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Oct 3, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 3, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 16, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 25, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Apr 25, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 14, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Feb 14, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 12, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jan 12, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 3, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 19, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 18, 2023	Form 144	Cytokinetics CYTK	Filing · EDGAR
Oct 3, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 5, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 18, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 15, 2023	Form 144	Cytokinetics CYTK	Filing · EDGAR
May 15, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 5, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 5, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Sep 12, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 12, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 11, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 1, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 1, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 8, 2022	Form 4/A	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Nov 5, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 4, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 8, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 13, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 8, 2021	Form 4/A	Cytokinetics CYTK	Filing · EDGAR
Apr 5, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 5, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 31, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 5, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 20, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 14, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 14, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 29, 2020	Form 4/A	Cytokinetics CYTK	Filing · EDGAR
Jan 6, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 2, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 6, 2019	Form 4	Myriad Genetics	Filing · EDGAR
Nov 20, 2019	Form 4	Cytokinetics CYTK	Filing · EDGAR
Nov 7, 2019	Form 4	Myriad Genetics	Filing · EDGAR
May 17, 2019	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2019	Form 4	Cytokinetics CYTK	Filing · EDGAR
Nov 30, 2018	Form 4	Myriad Genetics	Filing · EDGAR
Jul 13, 2018	Form 4	Myriad Genetics	Filing · EDGAR
May 17, 2018	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2018	Form 4	Cytokinetics CYTK	Filing · EDGAR
Nov 30, 2017	Form 4	Myriad Genetics	Filing · EDGAR
Sep 5, 2017	Form 4	Myriad Genetics	Filing · EDGAR
May 22, 2017	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 23, 2017	Form 4	Myriad Genetics	Filing · EDGAR
Jan 4, 2017	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 1, 2016	Form 4	Myriad Genetics	Filing · EDGAR
Sep 13, 2016	Form 4	Myriad Genetics	Filing · EDGAR
May 20, 2016	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 6, 2016	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 7, 2015	Form 4	Myriad Genetics	Filing · EDGAR
May 21, 2015	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 5, 2015	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 4, 2014	Form 4	Myriad Genetics	Filing · EDGAR
Jun 6, 2014	Form 4	Myriad Genetics	Filing · EDGAR
May 22, 2014	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 11, 2014	Form 4	Myriad Genetics	Filing · EDGAR
Mar 7, 2014	Form 4	Myriad Genetics	Filing · EDGAR
Jan 3, 2014	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 6, 2013	Form 4	Myriad Genetics	Filing · EDGAR
May 29, 2013	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 25, 2013	Form 4	Myrexis	Filing · EDGAR
Jan 4, 2013	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 11, 2012	Form 4	Myriad Genetics	Filing · EDGAR
Dec 5, 2012	Form 4	Myriad Genetics	Filing · EDGAR
May 24, 2012	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2012	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 12, 2011	Form 4	Myrexis	Filing · EDGAR
Dec 2, 2011	Form 4	Myriad Genetics	Filing · EDGAR
May 19, 2011	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2011	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 3, 2010	Form 4	Myriad Genetics	Filing · EDGAR
Nov 15, 2010	Form 4	Myrexis	Filing · EDGAR
May 21, 2010	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 5, 2010	Form 4	Cytokinetics CYTK	Filing · EDGAR
Nov 6, 2009	Form 4	Myriad Genetics	Filing · EDGAR
Jul 6, 2009	Form 4	Myrexis	Filing · EDGAR
Jun 11, 2009	Form 3	Myrexis	Filing · EDGAR
May 22, 2009	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 14, 2009	Form 4	Myriad Genetics	Filing · EDGAR
Apr 2, 2009	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 27, 2009	Form 3/A	Cytokinetics CYTK	Filing · EDGAR
Feb 20, 2009	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 20, 2009	Form 3	Cytokinetics CYTK	Filing · EDGAR
Feb 5, 2009	Form 4	Myriad Genetics	Filing · EDGAR
Nov 17, 2008	Form 4	Myriad Genetics	Filing · EDGAR
Nov 16, 2007	Form 4	Myriad Genetics	Filing · EDGAR
Nov 17, 2006	Form 4	Myriad Genetics	Filing · EDGAR
Jan 6, 2006	Form 4	Myriad Genetics	Filing · EDGAR
Nov 12, 2004	Form 4	Myriad Genetics	Filing · EDGAR
Oct 22, 2004	Form 4	Inveresk Research Group	Filing · EDGAR
May 11, 2004	Form 4	Myriad Genetics	Filing · EDGAR
May 6, 2004	Form 4	Inveresk Research Group	Filing · EDGAR
May 3, 2004	Form 4	Myriad Genetics	Filing · EDGAR
May 3, 2004	Form 3	Myriad Genetics	Filing · EDGAR
Mar 19, 2004	Form 4	Inveresk Research Group	Filing · EDGAR
Feb 12, 2004	Form 5	Inveresk Research Group	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 8:44 PM ET. The filing on SEC.gov is the record.